170 related articles for article (PubMed ID: 30181807)
21. Is 1 mm thickness sec. Breslow the correct cut-off for sentinel node biopsy in melanoma? Report of six cases of metastasis by thin melanoma.
Quarto G; Sivero L; Benassai G; Bucci L; Desiato V; Perrotta S; Benassai G; Massa S
Ann Ital Chir; 2013; 84(5):575-8. PubMed ID: 24141056
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution.
Roulin D; Matter M; Bady P; Liénard D; Gugerli O; Boubaker A; Bron L; Lejeune FJ
Eur J Surg Oncol; 2008 Jun; 34(6):673-9. PubMed ID: 17825518
[TBL] [Abstract][Full Text] [Related]
23. Is 0.75 mm Breslow thickness the correct cut-off point for performing sentinel node biopsy in patients with melanoma?
Doumas A; Dionyssopoulos A; Christoforidis T; Papaconstantinou A; Efstratiou I; Iakovou I; Lo-Presti D; Georga S; Nikos V; Karatzas N
Hell J Nucl Med; 2010; 13(3):253-6. PubMed ID: 21193880
[TBL] [Abstract][Full Text] [Related]
24. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
25. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.
Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS
Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784
[TBL] [Abstract][Full Text] [Related]
26. Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study.
Tejera-Vaquerizo A; Ribero S; Puig S; Boada A; Paradela S; Moreno-Ramírez D; Cañueto J; de Unamuno B; Brinca A; Descalzo-Gallego MA; Osella-Abate S; Cassoni P; Carrera C; Vidal-Sicart S; Bennássar A; Rull R; Alos L; Requena C; Bolumar I; Traves V; Pla Á; Fernández-Orland A; Jaka A; Fernández-Figueres MT; Hilari JM; Giménez-Xavier P; Vieira R; Botella-Estrada R; Román-Curto C; Ferrándiz L; Iglesias-Pena N; Ferrándiz C; Malvehy J; Quaglino P; Nagore E;
Cancer Med; 2019 Aug; 8(9):4235-4244. PubMed ID: 31215168
[TBL] [Abstract][Full Text] [Related]
27. Surgical management of regional lymph nodes in patients with melanoma. Experience with 4682 patients.
Slingluff CL; Stidham KR; Ricci WM; Stanley WE; Seigler HF
Ann Surg; 1994 Feb; 219(2):120-30. PubMed ID: 8129482
[TBL] [Abstract][Full Text] [Related]
28. Metastasis of primary melanoma to two separate lymph node basins: prognostic significance.
Dale PS; Foshag LJ; Wanek LA; Morton DL
Ann Surg Oncol; 1997 Jan; 4(1):13-8. PubMed ID: 8985512
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes--one institution's experience.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Melanoma Res; 2003 Feb; 13(1):35-43. PubMed ID: 12569283
[TBL] [Abstract][Full Text] [Related]
30. BILLCD8 - A Multivariable Survival Model as a Simple and Clinically Useful Prognostic Tool to Identify High-risk Cutaneous Melanoma Patients.
Donizy P; Biecek P; Halon A; Matkowski R
Anticancer Res; 2016 Sep; 36(9):4739-47. PubMed ID: 27630321
[TBL] [Abstract][Full Text] [Related]
31. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
[TBL] [Abstract][Full Text] [Related]
32. Sun exposure and melanoma prognostic factors.
Gandini S; Montella M; Ayala F; Benedetto L; Rossi CR; Vecchiato A; Corradin MT; DE Giorgi V; Queirolo P; Zannetti G; Giudice G; Borroni G; Forcignanò R; Peris K; Tosti G; Testori A; Trevisan G; Spagnolo F; Ascierto PA;
Oncol Lett; 2016 Apr; 11(4):2706-2714. PubMed ID: 27073541
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
[TBL] [Abstract][Full Text] [Related]
34. Sentinel lymph node biopsy does not change melanoma-specific survival among patients with Breslow thickness greater than four millimeters.
Caracò C; Celentano E; Lastoria S; Botti G; Ascierto PA; Mozzillo N
Ann Surg Oncol; 2004 Mar; 11(3 Suppl):198S-202S. PubMed ID: 15023751
[TBL] [Abstract][Full Text] [Related]
35. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
[TBL] [Abstract][Full Text] [Related]
36. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
Böni R; Doguoglu A; Burg G; Müller B; Dummer R
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
[TBL] [Abstract][Full Text] [Related]
37. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.
Lens MB; Dawes M; Newton-Bishop JA; Goodacre T
Br J Surg; 2002 Oct; 89(10):1223-7. PubMed ID: 12296887
[TBL] [Abstract][Full Text] [Related]
38. Predictors of sentinel lymph node status of cutaneous melanoma in Serbian patients.
Jokic S; Markovic I; Bukumiric Z; Jokic V; Rakovic M; Tripkovic J; Stojiljkovic D; Spurnic I; Jevric M; Matic M; Dobrosavljevic D
J BUON; 2018; 23(2):468-474. PubMed ID: 29745094
[TBL] [Abstract][Full Text] [Related]
39. Locoregional cutaneous metastasis in patients with therapeutic lymph node dissection for malignant melanoma: risk factors and prognostic impact.
Kretschmer L; Preusser KP; Neumann C
Melanoma Res; 2002 Oct; 12(5):499-504. PubMed ID: 12394192
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathologic Factors Predictive of Occult Lymph Node Involvement in Cutaneous Head and Neck Melanoma.
Yalamanchi P; Brant JA; Chen J; Newman JG
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):489-496. PubMed ID: 29112483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
